VEGFR
Los inhibidores del receptor del factor de crecimiento endotelial vascular (VEGFR) son compuestos que bloquean la señalización del VEGFR, un receptor clave en la vía del VEGF, crucial para la angiogénesis. Los inhibidores del VEGFR impiden la formación de nuevos vasos sanguíneos que suministran nutrientes y oxígeno a los tumores, inhibiendo así el crecimiento tumoral. Estos inhibidores se utilizan ampliamente en la terapia contra el cáncer y en la investigación para estudiar los mecanismos de la angiogénesis y desarrollar tratamientos anticancerígenos. En CymitQuimica, ofrecemos una gama completa de inhibidores de VEGFR de alta calidad para apoyar su investigación en oncología, biología vascular y angiogénesis.
Se han encontrado 271 productos para "VEGFR".
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Brivanib (alaninate)
CAS:Brivanib Alaninate (BMS-582664) is an alaninate salt of a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with potential antineoplastic effect.Fórmula:C22H24FN5O4Pureza:99.46% - 99.66%Forma y color:White SolidPeso molecular:441.46BIBF 1202
CAS:BIBF 1202 is a VEGFR2 kinase inhibitor (IC50 = 62 nM).Fórmula:C30H31N5O4Pureza:98.69%Forma y color:SolidPeso molecular:525.6Anti-Mouse VEGF Antibody (G6-31)
Anti-Mouse VEGF Antibody (G6-31) is a monoclonal antibody targeting mouse VEGF. It is applicable to angiogenesis-related research.Pureza:>95% (SDS-PAGE); 98.0% (SEC-HPLC) - >95% (SDS-PAGE); 98.69% (SEC-HPLC)Peso molecular:144.80 kDaIzenivetmab
CAS:Izenivetmab (ZTS-00075623) a caninized monoclonal antibody against NGFfor analgesia, anti-inflammatory effects, osteoarthritis and nociceptive signaling.Pureza:98.4% (SDS-PAGE); 98.5% (SEC-HPLC) - 98.4% (SDS-PAGE); 98.5% (SEC-HPLC)Forma y color:LiquidTarcocimab
CAS:Tarcocimab (OG1953) is a humanized IgG1 monoclonal antibody targeting VEGFA, researched for RVO and wet AMD.Pureza:95% - 95%Forma y color:LiquidAnti-Human/Rat VEGF Antibody (A.4.6.1)
Anti-Human/Rat VEGF Antibody (A.4.6.1) is for angiogenesis research.Pureza:95%Peso molecular:~150 kDaVarisacumab
CAS:Varisacumab (R 84) exhibits high affinity for VEGF-A with an IC50 of approximately 0.3 nM. Varisacumab significantly inhibits endothelial cell proliferation and reduces tumor vascular density in vivo.Pureza:95%Forma y color:LiquidPeso molecular:145.62 kDaTovecimig
Tovecimig is a G1-scFvlh_L-κ type bispecific antibody targeting VEGFA/DLL4.Forma y color:Odour LiquidInlecitug
CAS:Inlecitug is a chimeric monoclonal antibody targeting KDR that blocks VEGF binding to inhibit angiogenesis, showing potential for cancer research.Peso molecular:~150 kDaZM323881 hydrochloride
CAS:ZM323881 hydrochloride (ZM 323881 HCl) is a potent and selective VEGFR2 inhibitor.Fórmula:C22H19ClFN3O2Pureza:99.43%Forma y color:Yellow SolidPeso molecular:411.86Ref: TM-T1991
1mg34,00€5mg66,00€1mL*10mM (DMSO)69,00€10mg96,00€25mg225,00€50mg369,00€100mg550,00€200mg780,00€Suvemcitug
CAS:Suvemcitug, an IgG1κ antibody, specifically targets vascular endothelial growth factor (VEGF) and is derived from the African hare (Oryctolagus cuniculus) [1].Pureza:98%Forma y color:LiquidBucillamine
CAS:Bucillamine (DE019) protects against Ischemia/reperfusion injury in high-risk organ transplants and inhibits the production of VEGF.Fórmula:C7H13NO3S2Pureza:99.47%Forma y color:White SolidPeso molecular:223.31E3330
CAS:E3330 is a potent and selective APE1(Ref-1) inhibitor, which suppressed NF-kappa B DNA-binding activity.Fórmula:C21H30O6Pureza:99.52%Forma y color:SolidPeso molecular:378.46LYN00101
LYN00101 is a human monoclonal antibody (mAb) that targets VEGFA. It is utilized in research concerning cervical, colorectal, gastric, and ovarian cancers.Pazopanib Impurity 3
CAS:Pazopanib Impurity（VEGFR-2-IN-6 (WO 02/059110, example 64) ）is a potent inhibitor of VEGFR2, a crucial receptor involved in the regulation of angiogenesis [1].Fórmula:C20H21N7O2SPureza:99.11%Forma y color:SolidPeso molecular:423.49VGX200
VGX200 is a monoclonal antibody directed against vascular endothelial growth factor D (VEGFD).THR-317
THR-317 is a humanized monoclonal antibody (mAb) that targets PLGF. It is applicable in research on diabetic retinopathy.Anti-DCBLD2/CLCP1 Antibody (FA19-1)
Anti-DCBLD2CLCP1 Antibody (FA19-1) is a human monoclonal antibody (mAb) specifically targeting DCBLD2.MW02
MW02 is a human monoclonal antibody (mAb) targeting VEGFA. It is applicable in the study of wet age-related macular degeneration.Girancitug
CAS:Girancitug is a humanized IgG1κ monoclonal antibody inhibitor that targets VEGFR2/KDR/CD309. It effectively suppresses angiogenesis and is applicable in anti-angiogenic therapy research for cancers such as colorectal and ovarian cancer.
